Clinical Trial Update: Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing rifaximin with Xifaxan 200 mg for traveler’s diarrhea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Traveler Diarrhea

Drugs mentioned

• Rifaximin (rifaximin)
• XIFAXAN (rifaximin)

Snippet

Sponsor: Actavis Inc. | Conditions: Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2019-12-05